HomeCompareGRAMF vs PFE

GRAMF vs PFE: Dividend Comparison 2026

GRAMF yields 1260.24% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GRAMF wins by $145577708.49M in total portfolio value
10 years
GRAMF
GRAMF
● Live price
1260.24%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$145577708.54M
Annual income
$125,922,093,282,162.45
Full GRAMF calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — GRAMF vs PFE

📍 GRAMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGRAMFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GRAMF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GRAMF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GRAMF
Annual income on $10K today (after 15% tax)
$107,120.35/yr
After 10yr DRIP, annual income (after tax)
$107,033,779,289,838.08/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, GRAMF beats the other by $107,033,779,266,709.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GRAMF + PFE for your $10,000?

GRAMF: 50%PFE: 50%
100% PFE50/50100% GRAMF
Portfolio after 10yr
$72788854.29M
Annual income
$62,961,046,654,686.50/yr
Blended yield
86.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

GRAMF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
0.1
Piotroski
2/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GRAMF buys
0
PFE buys
0
No recent congressional trades found for GRAMF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGRAMFPFE
Forward yield1260.24%6.20%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$145577708.54M$51.1K
Annual income after 10y$125,922,093,282,162.45$27,210.54
Total dividends collected$144119665.53M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold

Year-by-year: GRAMF vs PFE ($10,000, DRIP)

YearGRAMF PortfolioGRAMF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$136,724$126,023.94$9,161$701.38+$127.6KGRAMF
2$1,756,621$1,610,326.24$8,610$859.79+$1.75MGRAMF
3$21,215,447$19,335,862.56$8,366$1,081.25+$21.21MGRAMF
4$240,950,361$218,249,832.96$8,483$1,405.66+$240.94MGRAMF
5$2,574,387,483$2,316,570,596.59$9,084$1,907.24+$2574.38MGRAMF
6$25,886,323,605$23,131,728,998.21$10,418$2,732.78+$25886.31MGRAMF
7$245,078,964,082$217,380,597,824.75$13,007$4,193.56+$245078.95MGRAMF
8$2,185,647,996,590$1,923,413,505,021.74$18,010$7,005.87+$2185647.98MGRAMF
9$18,369,733,884,259$16,031,090,527,907.70$28,216$12,979.89+$18369733.86MGRAMF
10$145,577,708,538,319$125,922,093,282,162.45$51,081$27,210.54+$145577708.49MGRAMF

GRAMF vs PFE: Complete Analysis 2026

GRAMFStock

TPCO Holding Corp., cultivates, extracts, manufactures, distributes, retails, and delivers cannabis in California. The company offers approximately 17 owned and licensed brands offering 250 stock keeping units across form-factors, such as jarred and bagged whole flower, pre-rolls, infused pre-rolls, bulk extracts, vaporizer cartridges, ready-to-use vapes, concentrates, gummies, chocolate, capsules, tinctures, topicals, and body care products. As of December 31, 2021, the Company operated eleven retail locations and six consumer delivery hubs; and four stores under the Caliva, Deli by Caliva, Coastal, and Calma brands, as well as through Caliva.com, a direct-to-consumer e-commerce platform. The company was formerly known as Subversive Capital Acquisition Corp. and changed its name to TPCO Holding Corp. in January 2021. TPCO Holding Corp. was incorporated in 2019 and is headquartered in San Jose, California.

Full GRAMF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this GRAMF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GRAMF vs SCHDGRAMF vs JEPIGRAMF vs OGRAMF vs KOGRAMF vs MAINGRAMF vs JNJGRAMF vs MRKGRAMF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.